Product Information

DEXTROAMP-AMPHETAMIN 15 MG TAB is a generic product labeled by Oryza Pharmaceuticals Inc., priced at $0.2423 per EA under NDC 72516001301. Its NADAC has been published 260 times since Mar 24, 2021.

DEA Schedule CII

Strength

3.75; 3.75; 3.75; 3.75 mg/1; mg/1; mg/1; mg/1

NDC

72516001301

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA210293

On Market Since

10/19/2020

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAMIN 15 MG TAB has been published 260 times since Mar 24, 2021, and over the history we have for it it has declined 35.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2423 per EA
All-time high$0.3741 (Apr 14, 2021)
All-time low$0.1838 (Nov 20, 2024)
52-week high$0.2936
52-week low$0.2423
Median price$0.2714
Average price$0.2721
Largest weekly change+39.5% (Feb 22, 2023)
Weeks tracked260
Tracking sinceMar 24, 2021

Price History

1W

0.0%

1M

-3.2%

3M

-8.9%

6M

-12.0%

1Y

-12.2%

3Y

-28.0%

5Y

-17.8%

All

-35.2%

Generic Alternatives

The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAMIN 15 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 15 MG TAB, manufactured by Oryza Pharmaceuticals Inc., is $0.2423 per EA (NDC 72516001301), effective Jun 24, 2026.

How has the price of DEXTROAMP-AMPHETAMIN 15 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 15 MG TAB has declined 35.2%. It has been tracked across 260 weekly CMS publications since Mar 24, 2021.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 15 MG TAB?

Since Mar 24, 2021, the NADAC for DEXTROAMP-AMPHETAMIN 15 MG TAB has ranged from a low of $0.1838 (Nov 20, 2024) to a high of $0.3741 (Apr 14, 2021), with a median of $0.2714 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 15 MG TAB?

7 NADAC-published products share the same active ingredient, strength, and dosage form as DEXTROAMP-AMPHETAMIN 15 MG TAB, but none are currently priced below it.

Who manufactures DEXTROAMP-AMPHETAMIN 15 MG TAB?

DEXTROAMP-AMPHETAMIN 15 MG TAB (NDC 72516001301) is labeled by Oryza Pharmaceuticals Inc., and CMS classifies it as a generic product.